Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

Dalhousie University

$25,000.00

The Role of Reactive Oxygen Species in Herpesvirus Infection

EF 2016-17

Résumé
Photodynamic Inc. (PDI) is a world leader in light-activated anti-microbial technologies that work bygenerating reactive oxygen species (ROS). The company has identified an opportunity to dramatically expandits product offerings with innovative anti-viral technologies. Infection with herpes simplex virus-1 (HSV-1) isvery common, with most individuals infected in early childhood. Initial infection of skin cells is often followedby the establishment of a dormant form of infection known as 'latency' in long-lived cells of the nervoussystem. Periodic reactivation from latency permits re-infection of skin cells near the site of initial infection,which facilitates virus spread. Latency is what allows herpesviruses to establish life-long infection.Viral infection of animal cells triggers antiviral responses. ROS can directly damage viral components andshape antiviral responses by modifying cellular antiviral proteins. It is clear that ROS play a major role inantiviral defence, both at the level of the individual cells, and in whole animals, but detailed understanding ofmolecular mechanisms is lacking.The primary objective of this collaborative project is to advance fundamental understanding of how ROSaffects cellular proteins that dictate responses to HSV-1 infection. PDI will provide proprietary plant extractsfor the project, along with light sources required to stimulate ROS production. Light-activated plant extractsand other sources of ROS will be administered to herpesvirus-infected cells, followed by measurement ofchanges in the composition of cellular antiviral proteins, and measurement of effects on virus replication.This collaboration represents a unique opportunity to generate new basic knowledge about how ROS shapesantiviral responses. A successful project will lead to future mechanistic studies and afford PDI the opportunityto make anti-viral research a core competency.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Nova Scotia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
507294-2016
Name nom
McCormick, Craig
Department département
Microbiology and Immunology
Organization id
79
Institution établissement
Dalhousie University
Province en
Nova Scotia
Province fr
Nouvelle-Écosse
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1551
Committee name en
Atlantic Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Atlantique
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
6400
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Life sciences research related to human health and disease
Research subject fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Partie
1
Nb partie
1
Application title
The Role of Reactive Oxygen Species in Herpesvirus Infection
Keyword
NSERC
Application summary
Photodynamic Inc. (PDI) is a world leader in light-activated anti-microbial technologies that work bygenerating reactive oxygen species (ROS). The company has identified an opportunity to dramatically expandits product offerings with innovative anti-viral technologies. Infection with herpes simplex virus-1 (HSV-1) isvery common, with most individuals infected in early childhood. Initial infection of skin cells is often followedby the establishment of a dormant form of infection known as 'latency' in long-lived cells of the nervoussystem. Periodic reactivation from latency permits re-infection of skin cells near the site of initial infection,which facilitates virus spread. Latency is what allows herpesviruses to establish life-long infection.Viral infection of animal cells triggers antiviral responses. ROS can directly damage viral components andshape antiviral responses by modifying cellular antiviral proteins. It is clear that ROS play a major role inantiviral defence, both at the level of the individual cells, and in whole animals, but detailed understanding ofmolecular mechanisms is lacking.The primary objective of this collaborative project is to advance fundamental understanding of how ROSaffects cellular proteins that dictate responses to HSV-1 infection. PDI will provide proprietary plant extractsfor the project, along with light sources required to stimulate ROS production. Light-activated plant extractsand other sources of ROS will be administered to herpesvirus-infected cells, followed by measurement ofchanges in the composition of cellular antiviral proteins, and measurement of effects on virus replication.This collaboration represents a unique opportunity to generate new basic knowledge about how ROS shapesantiviral responses. A successful project will lead to future mechanistic studies and afford PDI the opportunityto make anti-viral research a core competency.